
Opinion|Videos|September 6, 2024
Key Factors to Consider when Switching to Biosimilars
Author(s)Sophia Humphreys, PharmD, MHA
Dr Humphreys discusses key factors to consider when switching to biosimilars.
Advertisement
Episodes in this series

Video content above is prompted by the following:
- To what extent should the pharmacy team prioritize supporting the switch from a reference product to a biosimilar, and what factors should be considered in making this decision?
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
World Schizophrenia Day: One Pharmacist's Vision for Safer Schizophrenia Care
2
Hepatitis B Is Still Active: What Pharmacists Need to Know About Adult Transmission Rates and Vaccine Gaps
3
Can GLP-1 Receptor Agonists Improve Outcomes in Patients at Risk for Endometrial Cancer?
4
Retatrutide Delivers Bariatric-Level Weight Loss in Pivotal Phase 3 TRIUMPH-1 Trial
5

































































































































